Opendata, web and dolomites


Artificial intelligence for automated, standardised interpretation of DNA testing results

Total Cost €


EC-Contrib. €






 FastFinder project word cloud

Explore the words cloud of the FastFinder project. It provides you a very rough idea of what is the project "FastFinder" about.

grow    setting    uten    clear    public    algorithms    raised    intelligence    innovative    times    hiring    ku    costly    contracted    clinical    projected    usp    backed    team    eic    population    detection    stricter    venture    software    led    ageing    safety    treatment    million    successful    engineers    scientists    microsoft    tom    promotion    quality    healthcare    develops    pressure    record    ict    data    chronic    commercial    diseases    deloitte    personalised    workflow       genetic    health    start    gain    imec    additional    volumes    bio    implications    martens    substantially    molecular    revenue    labs    pull    standardised    business    food    coupled    winning    ugentec    human    gdp    biologists    belgian    solution    demanding    lab    automated    flanders    leuven    removes    market    award    2014    manual    errors    learning       wouter    2018    24    standards    solutions    automation    automate    pharma    platform    decisions    continues    coming    dna    faster    serious    2060    budgets    artificial    skilled    disruptive    innovation    extends    cagr    company    employees    university    founded    expenditure    highlights    centre    diagnostics    interpretation    45    boosting    machine    fastfinder    capital    advancing    tests    427    track    patients   

Project "FastFinder" data sheet

The following table provides information about the project.


Organization address
postcode: 3500
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-06-01   to  2017-11-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UGENTEC NV BE (HASSELT) coordinator 50˙000.00


 Project objective

UgenTec is an award winning Belgian bio-IT start-up that develops software for automated and standardised analysis of DNA detection tests. Founded in 2014, it is venture backed and as raised a capital of €3.45 million. The company is led by Wouter Uten and Tom Martens, both with a track record in successful business development. UgenTec has a contracted revenue of €427.000, a team of 24 software engineers, data scientists and molecular biologists and is supported by Deloitte, IMEC, KU Leuven university, EIC-ICT labs and Microsoft Innovation Centre Flanders. Public health expenditure in the EU continues to rise with projected growth at 8.5% of GDP in 2060, driven by an ageing population and associated rise in chronic diseases and the promotion of personalised healthcare, demanding molecular information. This highlights an increasing need for automation in molecular diagnostics, including software solutions for interpretation of results. The market for genetic analysis software will grow substantially at 6.9% CAGR already by 2018. There is a clear market pull for automated solutions: as genetic testing volumes are growing every year and quality standards become stricter, the lab budgets are coming under pressure. As a disruptive innovative solution to this problem, UgenTec has developed the FastFinder software platform, advancing state of the art artificial intelligence and machine learning algorithms to automate the interpretation of results in the genetic testing workflow. FastFinder USP allows interpretation 30 times faster than manual interpretation and removes human errors that can lead to serious – and often costly – implications in treatment decisions for patients. Platform application potential extends beyond a clinical setting, (e.g. pharma, food safety) boosting commercial gain. This innovation has a revenue potential for UgenTec of over €100 million within 10 years coupled to the hiring of 100 additional highly skilled employees.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FASTFINDER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FASTFINDER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More  


SME LOYALISER: fostering SME retailers through LOYALty Integrated SERvices

Read More